semaglutide cvot trial Cardiovascular risk reduction with once-weekly in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 Overview of the global PIONEER

(CNN) People taking tirzepatide injections lost more weight and were more likely to reach specific weight loss targets than those taking semaglutide, according to a new study

The branded drugs also can be more expensive

We analyzed reviews from Trustpilot, ConsumerAffairs, and independent review platforms to identify consistent patterns in what users report

To examine impacts of incretin-mediated weight loss on the risk of PDAC and LUAD, we utilized the highly obesogenic C57BL/6J model with diet induced obesity (DIO)

Thus, this could be a contributory factor to pregnancy

Semaglutide does not directly impact kidney function, but as both medications can affect blood pressure and blood flow to the kidneys, regular kidney function monitoring is advised for individuals taking both medications